GPT and tuberculosis: All treatments significantly reduced the levels of liver markers (ALT, AST, ALP, GGT, TB, and DB), but combination therapy was the most effective, particularly in the reduction of ALP and GGT, when compared with the monotherapy (Empa or Met) groups and the MASLD group (Figure 2a–d).